2 recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 2 |
| Phase 2 | 2 | Recruiting 2 |
Follow MBrace Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors ADC - Prostate Cancer Castration-resistant Prostate Cancer, Breast Cancer | Phase 1 / Phase 2 | Recruiting | MBrace Therapeutics | 150 | 2025-09-03 | 2026-02-17 |
| Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors Antibody-Drug Conjugate - Cancer | Phase 1 / Phase 2 | Recruiting | MBrace Therapeutics | 130 | 2023-11-07 | 2026-03-02 |
Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Neoplasms (1) · Pancreatic Neoplasms (1) · Prostatic Neoplasms (1)
Immunoconjugates (1)
United States (2)